Literature DB >> 15978962

Use of cervical cancer screening among insured women: the extent of missed opportunities.

Sajal K Chattopadhyay1, Shahul H Ebrahim, Guoyu Tao, Matthew T McKenna.   

Abstract

The objective of the study is to identify opportunities to improve cervical cancer screening among privately insured women. From MedStat's Marketscan database, we identified 735,181 women aged 21-64 years who remained in the same insurance plan during the entire period of 2000-2002. We obtained the percentages of women who had a Papanicolaou (Pap)-test reimbursement claim and any health-related claim during the 3-year period. For women without a Pap-test claim, we obtained information about the frequency of insurance claims, type of health-care provider, and type of insurance plan in which the women were enrolled. The multivariate logistic regression model was used to identify factors independently associated with not having a Pap test. Of the total sample, in the 3-year period, 96% had at least one health insurance reimbursement claim and 69% had at least one claim for a Pap test. Approximately, 87% of the women who had no Pap-test claim had a health claim; 44% of such claims were from primary care providers. In the multiple logistic regression model, factors that were independently associated with having no Pap test were old age, being dependents of employees, and enrollment in comprehensive insurance plans. Efforts to increase the use of cervical cancer screening service should consider additional risk factors besides lack of insurance coverage. Concerted efforts by insurance and health-care providers are needed to improve adherence to the recommended cervical cancer screening guidelines, both by consumers and service providers.

Entities:  

Mesh:

Year:  2004        PMID: 15978962     DOI: 10.1016/j.healthpol.2004.11.012

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  7 in total

1.  Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings.

Authors:  Patricia A Carney; Jean O'Malley; David I Buckley; Motomi Mori; David A Lieberman; Lyle J Fagnan; James Wallace; Betty Liu; Cynthia Morris
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

2.  Trust and distrust among Appalachian women regarding cervical cancer screening: a qualitative study.

Authors:  Ann Scheck McAlearney; Jill M Oliveri; Douglas M Post; Paula H Song; Elizabeth Jacobs; Jason Waibel; J Phil Harrop; Kenneth Steinman; Electra D Paskett
Journal:  Patient Educ Couns       Date:  2011-04-01

3.  Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System.

Authors:  Sandi L Pruitt; Claudia L Werner; Eric K Borton; Joanne M Sanders; Bijal A Balasubramanian; Arti Barnes; Andrea C Betts; Celette Sugg Skinner; Jasmin A Tiro
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09-05       Impact factor: 4.254

4.  Papanicolaou test utilization and frequency of screening opportunities among women diagnosed with cervical cancer.

Authors:  Kathleen Decker; Alain Demers; Daniel Chateau; Grace Musto; Zoann Nugent; Robert Lotocki; Marion Harrison
Journal:  Open Med       Date:  2009-08-11

5.  Factors Associated With Low-Value Cancer Screenings in the Veterans Health Administration.

Authors:  Linnaea Schuttner; Bjarni Haraldsson; Charles Maynard; Christian D Helfrich; Ashok Reddy; Toral Parikh; Karin M Nelson; Edwin Wong
Journal:  JAMA Netw Open       Date:  2021-10-01

Review 6.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

7.  Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: what remains to be achieved by French national programmes?

Authors:  Jonathan Sicsic; Carine Franc
Journal:  BMC Health Serv Res       Date:  2014-10-04       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.